MDB Capital Holdings
  • About
    • About Us
    • Team
    • Holistic Model
  • Criteria
  • Process
  • Community
  • Companies
  • Investors
  • Submit Your Big Idea
Select Page

MDB Capital Holdings Announces Third MDB-Launched Company to Achieve FDA Approval

by Jim Foley | Nov 29, 2022 | Press Releases

DALLAS, T.X. / ACCESSWIRE / November 29, 2022 / MDB Capital Holdings, LLC, a privately-held public venture platform with the objective of growing the public venture marketplace and optimizing the way meaningful technologies are financed and built, today announced that...

Public Ventures LLC Completes First Public Company Financing as a Broker-Dealer for Cue Biopharma, Inc. (Nasdaq:CUE)

by Jim Foley | Nov 17, 2022 | Press Releases

DALLAS, TX / ACCESSWIRE / November 17, 2022 / Public Ventures, LLC, a wholly owned subsidiary of MDB Capital Holdings, LLC, completed its first financing as a broker-dealer for Cue Biopharma, Inc. (NASDAQ:CUE). The Public Ventures’ portion of the financing was...

MDB Capital Holdings Announces Filing of Registration Statement for Proposed Offering and Listing on Nasdaq

by Jim Foley | Nov 11, 2022 | Press Releases

DALLAS, TX / ACCESSWIRE / November 11, 2022 / MDB Capital Holdings, LLC (“MDB”), a privately-held public venture platform with the objective of growing the public venture marketplace and optimizing the way meaningful technologies are financed and built, today...

Recent Posts

  • MDB Capital Holdings Announces Closing of Public Offering of $20 Million
  • Video: MDB Capital Holdings Offering Presentation (Tahoe)
  • Video: MDB Capital Holdings Offering Presentation
  • Sanofi to acquire Provention Bio, adding to portfolio TZIELD, the first disease-modifying treatment for the delay of Stage 3 type 1 diabetes (T1D)
  • MDB Capital Holdings Announces Third MDB-Launched Company to Achieve FDA Approval

Recent Comments

    Archives

    • September 2023
    • August 2023
    • March 2023
    • November 2022
    • October 2022
    • August 2022
    • July 2022
    • June 2022

    Categories

    • Press Releases
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    AboutCriteriaProcessCommunityCompaniesTeamInvestorsContact

    Governance   Terms of Use   Business Continuity
    © 2023 MDB Capital Holdings